Chichili GR, Smulders R, Santos V, Cywin B, et al. Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years. Vaccine 2022 Jun 8. pii: S0264-410X(22)00715.
PMID: 35690500